Executive summary

This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median dose of 54 GyE with daily fractions of 2 GyE. With a median follow-up time of 42.2 months, this study reported stabilisation of tumour size on MRI in all patients. No changes in symptoms were observed in comparison with pre-treatment conditions. No late effects of radiotherapy were observed. 

Key content topics
Top cancer treatments